Thomas Arnhold

Thomas Arnhold has extensive work experience in the pharmaceutical industry, primarily at Boehringer Ingelheim. Thomas began their career in 1999 as a Lab Head, where they were responsible for overseeing a team and conducting various research projects. Throughout their tenure, Thomas took on increasingly senior roles, including Principal Scientist and Senior Clinical Pharmacokineticist. In these roles, they led projects, conducted preclinical PK studies, and collaborated in multidisciplinary teams. Thomas also played a key role in setting up and implementing automated medium throughput screening and prediction models for ADME behavior. From 2018 to 2020, they worked as a Principal Clinical Pharmacokineticist at Boehringer Ingelheim Pharma, where they continued to contribute to clinical pharmacology and data evaluation. Thomas's most recent position is at Boehringer Ingelheim, where they hold the title of Principal Expert Digital Tools and Data Excellence. In this role, they are involved in the development and implementation of digital tools to enhance data analysis and reporting processes. Throughout their career, Thomas has demonstrated expertise in clinical pharmacology, data analysis, and project management.

Thomas Arnhold has a PhD in Vitamin A metabolism and (reproductive) toxicology from the School of Veterinary Medicine Hannover, which they obtained from 1997 to 1999. Prior to that, they also completed a PhD in the same field from Freie Universität Berlin from 1995 to 1997. Their earlier education includes a degree as a Staatliche geprüfter Lebensmittelchemiker in Food Chemistry from Technische Universität Braunschweig, which they received from 1989 to 1995. There is no information available about their education at Andreanum.